See the published version of this preprint at BMC Public Health.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research article
Javier Jerez Roig
Universitat de Vic - Universitat Central de Catalunya
Corresponding Author
ORCiD: https://orcid.org/0000-0002-1968-4452
License:
This work is licensed under a CC BY 4.0 License. Read Full License
Background: The objective of this work was to analyse the prevalence trends of multimorbidity among European community-dwelling adults.
Methods: A temporal series study based on waves 1, 2, 4, 5, 6 and 7 of the Survey of Health, Ageing and Retirement in Europe (SHARE) was conducted, and community-dwelling participants aged 50+ (n=274,614) from 15 European countries were selected for the period 2004-2017. Prevalence, adjusted by age, Average Annual Percentage Change (APC) and 95% confidence interval (95% CI) were all calculated. Trend analyses were realised by period, age groups and groups of diseases.
Results: The results showed a large variability in the prevalence of multimorbidity in adults aged 50 and over among European countries. Increase in the prevalence of multimorbidity in the countries of central Europe (Austria, Belgium, Czech Republic, France, Germany and Switzerland) and Spain in both sexes, and in the Netherlands among men. Stability was observed in northern and eastern European countries. Musculoskeletal and neurodegenerative groups showed more significant changes in the trend analyses.
Conclusions: This information can be useful for policy makers when planning health promotion and prevention policies addressing modifiable risk factors in health.
Keywords
prevalence, older adults, non-communicable diseases, Europe, SHARE
Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
Loading...
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at BMC Public Health.
Version 3
Posted 17 Dec, 2020
No community comments so far
Editorial decision: Accept
On 16 Dec, 2020
Editor assigned
On 06 Dec, 2020
Submission checks complete
On 06 Dec, 2020
Editor invited
On 06 Dec, 2020
No comments provided
Editorial decision: Minor revision
On 03 Dec, 2020
Review #1 received
Received 19 Nov, 2020
Reviewer #1 agreed
On 09 Nov, 2020
Reviewers invited
Invitations sent on 08 Oct, 2020
Editor assigned
On 30 Sep, 2020
Submission checks complete
On 29 Sep, 2020
Editor invited
On 29 Sep, 2020
No comments provided
Editorial decision: Major revision
On 03 Sep, 2020
Review #1 received
Received 18 Aug, 2020
Review #2 received
Received 27 Jul, 2020
Reviewer #2 agreed
On 20 Jul, 2020
Reviewer #1 agreed
On 16 Jul, 2020
Reviewers invited
Invitations sent on 19 Mar, 2020
Editor assigned
On 04 Mar, 2020
Submission checks complete
On 03 Mar, 2020
Editor invited
On 03 Mar, 2020
First submitted
On 02 Mar, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Health Policy
Learn more about our company.
See the published version of this preprint at BMC Public Health.
This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice.
Learn more about In Review
Research article
Javier Jerez Roig
Universitat de Vic - Universitat Central de Catalunya
Corresponding Author
ORCiD: https://orcid.org/0000-0002-1968-4452
Badges
Prescreen
This manuscript passed our Prescreen assessment
Complete author information
Appropriate declaration statements
Potential risks to human health
Prescreen
Peer Review Timeline
CURRENT STATUS: Published
View the published article at BMC Public Health.
Version 3
Posted 17 Dec, 2020
No community comments so far
Editorial decision: Accept
On 16 Dec, 2020
Editor assigned
On 06 Dec, 2020
Submission checks complete
On 06 Dec, 2020
Editor invited
On 06 Dec, 2020
No comments provided
Editorial decision: Minor revision
On 03 Dec, 2020
Review #1 received
Received 19 Nov, 2020
Reviewer #1 agreed
On 09 Nov, 2020
Reviewers invited
Invitations sent on 08 Oct, 2020
Editor assigned
On 30 Sep, 2020
Submission checks complete
On 29 Sep, 2020
Editor invited
On 29 Sep, 2020
No comments provided
Editorial decision: Major revision
On 03 Sep, 2020
Review #1 received
Received 18 Aug, 2020
Review #2 received
Received 27 Jul, 2020
Reviewer #2 agreed
On 20 Jul, 2020
Reviewer #1 agreed
On 16 Jul, 2020
Reviewers invited
Invitations sent on 19 Mar, 2020
Editor assigned
On 04 Mar, 2020
Submission checks complete
On 03 Mar, 2020
Editor invited
On 03 Mar, 2020
First submitted
On 02 Mar, 2020
Metrics
Comments: 0
PDF Downloads: ...
HTML Views: ...
Subject Areas
Health Policy
License:
This work is licensed under a CC BY 4.0 License. Read Full License
View the published article at BMC Public Health.
Background: The objective of this work was to analyse the prevalence trends of multimorbidity among European community-dwelling adults.
Methods: A temporal series study based on waves 1, 2, 4, 5, 6 and 7 of the Survey of Health, Ageing and Retirement in Europe (SHARE) was conducted, and community-dwelling participants aged 50+ (n=274,614) from 15 European countries were selected for the period 2004-2017. Prevalence, adjusted by age, Average Annual Percentage Change (APC) and 95% confidence interval (95% CI) were all calculated. Trend analyses were realised by period, age groups and groups of diseases.
Results: The results showed a large variability in the prevalence of multimorbidity in adults aged 50 and over among European countries. Increase in the prevalence of multimorbidity in the countries of central Europe (Austria, Belgium, Czech Republic, France, Germany and Switzerland) and Spain in both sexes, and in the Netherlands among men. Stability was observed in northern and eastern European countries. Musculoskeletal and neurodegenerative groups showed more significant changes in the trend analyses.
Conclusions: This information can be useful for policy makers when planning health promotion and prevention policies addressing modifiable risk factors in health.
Figure 1
Figure 1
Figure 2
Figure 2
Figure 3
Figure 3
Loading...